[144] Milestone Scientific, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice filed regarding proposed sale of 400,000 shares of Milestone Scientific, Inc. common stock, with an aggregate market value of $236,000, scheduled approximately for 09/10/2025 on the NYSE. The filing lists 78,559,147 shares outstanding for the class. The securities to be sold were originally acquired in a private placement on 05/14/2014 (2,000,000 shares) from Milestone Scientific, paid in cash. The form also reports a recent sale by BP4 Srl of 375,485 shares on 06/02/2025 for $301,082. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Detailed transaction disclosure including number of shares, aggregate market value, and approximate sale date
• Acquisition history provided (private placement date and payment method), supporting Rule 144 eligibility
• Recent related sale disclosed (BP4 Srl sale on 06/02/2025) with gross proceeds

Negative

• Issuer identification fields appear blank in the provided content (issuer name, SEC file number, issuer address missing)
• Filer identification/contact information missing (CIK, contact name, phone, and email not provided in the content)

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 filing documenting a planned resale and recent sale; contains some missing issuer contact fields.

The filing is a standard Rule 144 notice describing a planned sale of restricted/controlled shares and documents acquisition details from a 2014 private placement. It properly discloses the intended exchange (NYSE), approximate sale date, number of shares outstanding, and a recent related-party sale. Material compliance information is present, but key administrative fields (filer CIK/contact, issuer name/address) appear blank in the provided content, which may hinder verification and public tracking.

Equity Markets Analyst

TL;DR: Non-material resale notice relative to total outstanding shares; shows historic private placement origin.

This Form 144 documents a planned disposition of 400,000 shares against an outstanding base of 78,559,147 shares, indicating the transaction is small in absolute percentage terms. The filing clarifies the original acquisition was a private placement in May 2014, paid in cash, which helps establish the holding period and Rule 144 eligibility. The recent sale by BP4 Srl is disclosed with proceeds of $301,082, providing context on recent liquidity events involving related holdings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Intesa San Paolo SPA Corso Venezia Milan L6 20121	400000	236000.00	78559147	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/14/2014	Private Placement Purchase	Milestone Scientific Inc.			2000000	05/12/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BP4 Srl corso venezia 44 Milan L6 20121	Milestone Scientific Inc common stock	06/02/2025	375485	301082.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MLSS Form 144 disclose about the shares to be sold?

The filing reports a proposed sale of 400,000 Milestone Scientific (MLSS) common shares with an aggregate market value of $236,000, approximately on 09/10/2025 on the NYSE.

When and how were the shares being sold originally acquired?

The securities to be sold were acquired in a private placement on 05/14/2014, from Milestone Scientific Inc., with payment in cash.

Has the filer recently sold Milestone Scientific shares?

Yes. The filing discloses that BP4 Srl sold 375,485 shares on 06/02/2025 for $301,082 in gross proceeds.

How many MLSS shares are outstanding according to the filing?

The filing shows 78,559,147 shares outstanding for the class disclosed.

Does the filing state whether the seller knows of any undisclosed material information?

Yes. The signer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.